Navigation Links
Baldness Drug May Cause Sexual Side Effects: FDA
Date:4/13/2012

By Steven Reinberg
HealthDay Reporter

THURSDAY, April 12 (HealthDay News) -- Two Merck & Co. drugs -- one to treat hair loss in men, the other to treat an enlarged prostate gland -- will get revised labels warning of potential sexual side effects that can last even after patients stop taking the drugs, the U.S. Food and Drug Administration said Thursday.

The two drugs -- Propecia to combat male pattern baldness, and Proscar, to treat enlarged prostates -- share the same chemical compound, called finasteride. One dose of Propecia contains 1 milligram of finasteride; one dose of Proscar contains 5 milligrams.

The new Propecia label will include a warning of "libido disorders, ejaculation disorders, and orgasm disorders that continued after discontinuation of the drug," the FDA said in a news release.

The Proscar label will include a warning about "decreased libido that continued after discontinuation of the drug," the agency said.

The labels of both drugs will also carry about a description of reports of male infertility and/or poor semen quality that clears up or improves after the drugs are stopped.

Although a cause-and-effect relationship between the drugs and these side effects hasn't been established, case reports suggest there's a potential problem, the FDA said.

The agency added, however, that only a small percentage of men using these drugs have experienced an adverse sexual event.

The FDA said it believes the drugs are safe to take for their approved uses. It recommends that patients and their doctors consider the new information on the revised labels when weighing a best treatment option.

Last year, both drugs' labels were changed to warn of the possibility of erectile dysfunction even after discontinuing the drug, according to the FDA.

Dr. Anthony D'Amico, chief of genitourinary radiation oncology at Brigham and Women's Hospital in Boston, said Thursday that the revised labels contain "an important message that people need to hear."

"Particularly because Propecia is used by 20- and 30-year-olds for hair loss and these are people of childbearing age, so if they are getting issues with fertility that a big issue," he said.

In a statement released Thursday afternoon, Merck said:

"Merck believes that Propecia and Proscar are generally well tolerated and effective for their respective intended uses in accordance with their approved product labeling. In addition, please note that a causal relationship between the use of Propecia or Proscar and continued sexual dysfunction after discontinuation of treatment has not been established."

D'Amico said Thursday's announcement from the FDA "points up the usefulness of post-marketing studies on drugs that have been studied, but not for long enough periods to know what can happen when large numbers of people use them and what happens when they are discontinued."

More information

For more on the label changes, visit the U.S. Food and Drug Administration.

SOURCES: Anthony D'Amico, M.D., chief of genitourinary radiation oncology, Brigham and Women's Hospital, Boston; April 12, 2012, news release, U.S. Food and Drug Administration; April 12, 2012, news release, Merck & Co., Whitehouse Station, N.J.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study Offers Insights Into Male Pattern Baldness
2. Hair Loss Research Study Reveals Important Breakthrough in the Treatment of Male Pattern Baldness
3. Stem Cell Defect Might Help Spur Common Baldness
4. Mouse Study Could Give New Clues to Fighting Baldness
5. Research Spots Potential New Target in Fight Against Baldness
6. Obstructive Sleep Apnea in Kids May Have Genetic Cause
7. UCLA study reveals how genes interact with their environment to cause disease
8. Virus Unlikely to Cause Chronic Fatigue Syndrome
9. RSA Innovator NetClarity Solves Networking Problems Caused by HP and Cisco Divorce
10. Popular nanoparticle causes toxicity in fish, study shows
11. Genetic cause discovered for rare bleeding disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... ... the past six years, Lightning Labels has sent out a call for users of its ... and creativity of their designs. Submissions this year were open from May 18 to July ... the winners of the sixth annual Photo Contest, along with the prizes they've received:, ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... “To Walk ... radioman on a B17 bomber named Edward Koontz. “To Walk Away” is the creation ... Scranton, who has published over two hundred manuscripts in chemistry and religion, as well ...
(Date:8/22/2017)... ... ... “Glimpses Of Light”: is a unique and thought inspiring guide toward self-discovery and ... author, J.M. Shepherd, a writer, teacher, traveler, and metaphysician, the author has spent most ... “Love is one of the least understood and yet most sought-after pleasures known to ...
(Date:8/22/2017)... ... ... Although Labor Day is not as popular for fireworks as New Year’s ... numerous households celebrate the unofficial end of summer with backyard fireworks shows. While fireworks ... Kris Zambo, owner of Dynamite Fireworks in Hammond, Indiana, provides 5 tips ...
(Date:8/21/2017)... ... August 21, 2017 , ... Los Angeles ... surgery fellows for academic year 2017-2018, Christina M. Busuito, M.D. and Lukasz Swistun, ... residency in Plastic and Reconstructive Surgery. The candidate will have the opportunity ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... WASHINGTON , Aug. 2, 2017 CaryRx, a ... same day delivery service for patients in the ... the traditional retail pharmacy by providing delivery of medications through ... scheduled for future delivery or delivered within one hour to ... "We are excited to bring this invaluable service to ...
(Date:7/31/2017)... Three Tru-D SmartUVC robots have arrived at Brian Allgood Army ... short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 germ-killing robot that ... professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at Army hospitals ... "Although the BAACH has a very low infection rate, below ...
(Date:7/28/2017)... , July 28, 2017 EnvoyHealth, a Diplomat ... pilot a program for CleverCap LITE, a technology designed ... strives to deliver innovative health technology solutions and services ... CleverCap LITE offers medication ... high-tech bottle cover: ...
Breaking Medicine Technology: